Table 3 MicroRNAs significantly associated with response to treatment.

From: microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

MicroRNA

Base Mean

log2FoldChange

pvalue

padj

hsa-miR-12136

120.0

25.73

1.29 × 10–13

9.70 × 10–11

hsa-miR-129a-5p

42.7

5.09

2.86 × 10–09

1.08 × 10–06

hsa-miR-129-1-3p

7.4

4.08

1.86 × 10–06

0.00035

hsa-miR-3150b-3p

50.7

2.33

1.60 × 10–05

0.00241

hsa-miR-127-3p

3977.2

2.01

6.14 × 10–05

0.00661

hsa-miR-3681-5p

75.3

2.34

0.00016

0.01507

hsa-miR-370-3p

16.1

2.59

0.00041

0.02380

hsa-miR-4464

3.3

3.55

0.00117

0.04641

hsa-miR-129b-5p

27.5

2.88

0.00102

0.04641

hsa-miR-3928-3p

16.5

2.03

0.00113

0.04641

hsa-miR-192-5p

10,375.5

− 2.41

1.60 × 10–07

4.01 × 10–05

  1. Positive Log2 Fold change represented the overexpression of microRNAs at diagnosis in patients with complete remission compared with refractory patients; and negative, downregulation in the same group of patients; Base Mean: represented the average of the normalized count values, dividing by size factors, taken over all samples.
Back to article page